Go Pro

GE HealthCare Technologies (GEHC) Competitors

GE HealthCare Technologies logo
$72.94 +1.17 (+1.63%)
Closing price 08/10/2026 04:00 PM Eastern
Extended Trading
$73.16 +0.22 (+0.30%)
As of 04:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GEHC vs. PHG, MDT, BSX, EW, and BDX

Should you buy GE HealthCare Technologies stock or one of its competitors? GE HealthCare Technologies's main competitors and comparable companies include Koninklijke Philips (PHG), Medtronic (MDT), Boston Scientific (BSX), Edwards Lifesciences (EW), and Becton, Dickinson and Company (BDX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does GE HealthCare Technologies compare to Koninklijke Philips?

Koninklijke Philips (NYSE:PHG) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

13.7% of Koninklijke Philips shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Koninklijke Philips has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

In the previous week, Koninklijke Philips had 5 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 11 mentions for Koninklijke Philips and 6 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.12 beat Koninklijke Philips' score of 0.75 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Koninklijke Philips
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has a consensus price target of $77.73, suggesting a potential upside of 6.56%. Given GE HealthCare Technologies' stronger consensus rating and higher possible upside, analysts plainly believe GE HealthCare Technologies is more favorable than Koninklijke Philips.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Koninklijke Philips
1 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.80
GE HealthCare Technologies
1 Sell rating(s)
10 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

GE HealthCare Technologies has higher revenue and earnings than Koninklijke Philips. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Koninklijke Philips, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Koninklijke Philips$20.17B1.31$1.01B$1.3619.79
GE HealthCare Technologies$20.63B1.60$2.08B$4.3616.73

Koninklijke Philips pays an annual dividend of $0.84 per share and has a dividend yield of 3.1%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Koninklijke Philips pays out 61.8% of its earnings in the form of a dividend. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. GE HealthCare Technologies has increased its dividend for 1 consecutive years.

GE HealthCare Technologies has a net margin of 9.33% compared to Koninklijke Philips' net margin of 6.30%. GE HealthCare Technologies' return on equity of 20.12% beat Koninklijke Philips' return on equity.

Company Net Margins Return on Equity Return on Assets
Koninklijke Philips6.30% 14.38% 5.96%
GE HealthCare Technologies 9.33%20.12%5.74%

Summary

GE HealthCare Technologies beats Koninklijke Philips on 14 of the 19 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Medtronic?

Medtronic (NYSE:MDT) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

In the previous week, Medtronic had 29 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 35 mentions for Medtronic and 6 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.12 beat Medtronic's score of 0.79 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Medtronic
19 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Medtronic has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

Medtronic currently has a consensus target price of $98.83, indicating a potential upside of 10.66%. GE HealthCare Technologies has a consensus target price of $77.73, indicating a potential upside of 6.56%. Given Medtronic's stronger consensus rating and higher probable upside, equities research analysts clearly believe Medtronic is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Medtronic
0 Sell rating(s)
9 Hold rating(s)
18 Buy rating(s)
0 Strong Buy rating(s)
2.67
GE HealthCare Technologies
1 Sell rating(s)
10 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

Medtronic has higher revenue and earnings than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Medtronic, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$36.36B3.14$4.80B$3.7323.94
GE HealthCare Technologies$20.63B1.60$2.08B$4.3616.73

Medtronic has a net margin of 13.20% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Medtronic's return on equity.

Company Net Margins Return on Equity Return on Assets
Medtronic13.20% 14.51% 7.76%
GE HealthCare Technologies 9.33%20.12%5.74%

Medtronic pays an annual dividend of $2.88 per share and has a dividend yield of 3.2%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Medtronic pays out 77.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Medtronic has increased its dividend for 49 consecutive years and GE HealthCare Technologies has increased its dividend for 1 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

82.1% of Medtronic shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Medtronic shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Medtronic beats GE HealthCare Technologies on 12 of the 18 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

89.1% of Boston Scientific shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.3% of Boston Scientific shares are owned by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Boston Scientific has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market.

In the previous week, Boston Scientific had 15 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 21 mentions for Boston Scientific and 6 mentions for GE HealthCare Technologies. Boston Scientific's average media sentiment score of 1.21 beat GE HealthCare Technologies' score of 1.12 indicating that Boston Scientific is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Boston Scientific
12 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Boston Scientific has higher earnings, but lower revenue than GE HealthCare Technologies. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boston Scientific$20.07B3.64$2.90B$2.4720.41
GE HealthCare Technologies$20.63B1.60$2.08B$4.3616.73

Boston Scientific has a net margin of 17.50% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Boston Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Boston Scientific17.50% 19.28% 10.89%
GE HealthCare Technologies 9.33%20.12%5.74%

Boston Scientific presently has a consensus target price of $71.62, indicating a potential upside of 42.04%. GE HealthCare Technologies has a consensus target price of $77.73, indicating a potential upside of 6.56%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts clearly believe Boston Scientific is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Boston Scientific
2 Sell rating(s)
5 Hold rating(s)
24 Buy rating(s)
0 Strong Buy rating(s)
2.71
GE HealthCare Technologies
1 Sell rating(s)
10 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

Summary

Boston Scientific beats GE HealthCare Technologies on 11 of the 16 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Edwards Lifesciences?

Edwards Lifesciences (NYSE:EW) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

GE HealthCare Technologies has higher revenue and earnings than Edwards Lifesciences. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edwards Lifesciences$6.07B8.73$1.07B$1.7452.88
GE HealthCare Technologies$20.63B1.60$2.08B$4.3616.73

In the previous week, Edwards Lifesciences had 2 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 8 mentions for Edwards Lifesciences and 6 mentions for GE HealthCare Technologies. Edwards Lifesciences' average media sentiment score of 1.27 beat GE HealthCare Technologies' score of 1.12 indicating that Edwards Lifesciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Edwards Lifesciences
6 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Edwards Lifesciences currently has a consensus price target of $100.27, suggesting a potential upside of 8.98%. GE HealthCare Technologies has a consensus price target of $77.73, suggesting a potential upside of 6.56%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, equities analysts clearly believe Edwards Lifesciences is more favorable than GE HealthCare Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Edwards Lifesciences
0 Sell rating(s)
6 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.74
GE HealthCare Technologies
1 Sell rating(s)
10 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

Edwards Lifesciences has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, suggesting that its stock price is 31% less volatile than the broader market.

Edwards Lifesciences has a net margin of 15.43% compared to GE HealthCare Technologies' net margin of 9.33%. GE HealthCare Technologies' return on equity of 20.12% beat Edwards Lifesciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Edwards Lifesciences15.43% 15.68% 12.05%
GE HealthCare Technologies 9.33%20.12%5.74%

79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.3% of Edwards Lifesciences shares are held by company insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Edwards Lifesciences beats GE HealthCare Technologies on 10 of the 16 factors compared between the two stocks.

How does GE HealthCare Technologies compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 82.1% of GE HealthCare Technologies shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by insiders. Comparatively, 0.4% of GE HealthCare Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

GE HealthCare Technologies has a net margin of 9.33% compared to Becton, Dickinson and Company's net margin of 4.52%. GE HealthCare Technologies' return on equity of 20.12% beat Becton, Dickinson and Company's return on equity.

Company Net Margins Return on Equity Return on Assets
Becton, Dickinson and Company4.52% 14.84% 6.93%
GE HealthCare Technologies 9.33%20.12%5.74%

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.3%. GE HealthCare Technologies pays an annual dividend of $0.14 per share and has a dividend yield of 0.2%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. GE HealthCare Technologies pays out 3.2% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years and GE HealthCare Technologies has raised its dividend for 1 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Becton, Dickinson and Company presently has a consensus target price of $185.00, suggesting a potential upside of 3.02%. GE HealthCare Technologies has a consensus target price of $77.73, suggesting a potential upside of 6.56%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Becton, Dickinson and Company.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Becton, Dickinson and Company
1 Sell rating(s)
8 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.41
GE HealthCare Technologies
1 Sell rating(s)
10 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Becton, Dickinson and Company had 29 more articles in the media than GE HealthCare Technologies. MarketBeat recorded 35 mentions for Becton, Dickinson and Company and 6 mentions for GE HealthCare Technologies. GE HealthCare Technologies' average media sentiment score of 1.12 beat Becton, Dickinson and Company's score of 0.66 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Becton, Dickinson and Company
12 Very Positive mention(s)
2 Positive mention(s)
14 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Becton, Dickinson and Company has a beta of 0.19, meaning that its share price is 81% less volatile than the broader market. Comparatively, GE HealthCare Technologies has a beta of 0.69, meaning that its share price is 31% less volatile than the broader market.

GE HealthCare Technologies has lower revenue, but higher earnings than Becton, Dickinson and Company. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Becton, Dickinson and Company$21.84B2.27$1.68B$3.3254.09
GE HealthCare Technologies$20.63B1.60$2.08B$4.3616.73

Summary

GE HealthCare Technologies beats Becton, Dickinson and Company on 10 of the 19 factors compared between the two stocks.

Get GE HealthCare Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for GEHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GEHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GEHC vs. The Competition

MetricGE HealthCare TechnologiesHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$32.42B$5.82B$7.01B$12.98B
Dividend Yield0.20%1.78%2.58%10.07%
P/E Ratio16.7324.72269.2024.72
Price / Sales1.6061.04592.8398.22
Price / Cash12.2133.5528.8937.42
Price / Book3.206.2111.396.42
Net Income$2.08B$147.87M$3.45B$347.03M
7 Day Performance3.81%1.06%1.92%0.69%
1 Month Performance12.74%1.63%-0.57%-0.90%
1 Year Performance-0.08%5.36%75.49%21.87%

GE HealthCare Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GEHC
GE HealthCare Technologies
4.4787 of 5 stars
$72.94
+1.6%
$77.73
+6.6%
+1.3%$32.42B$20.63B16.7354,000
PHG
Koninklijke Philips
2.9859 of 5 stars
$26.22
-0.3%
N/A+0.2%$25.85B$20.17B19.3265,340
MDT
Medtronic
4.7737 of 5 stars
$86.67
+1.5%
$98.83
+14.0%
-3.9%$109.30B$36.36B23.2395,000
BSX
Boston Scientific
4.7683 of 5 stars
$48.46
+3.7%
$71.62
+47.8%
-51.2%$69.46B$20.07B19.6259,000
EW
Edwards Lifesciences
3.7047 of 5 stars
$88.75
+3.1%
$100.27
+13.0%
+17.4%$49.56B$6.07B51.0016,000

Related Companies and Tools


This page (NASDAQ:GEHC) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners